Your browser doesn't support javascript.
loading
Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial.
Warren, Rachel A; Carew, Allie S; Andreou, Pantelis; Herman, Christine; Levy, Andrew P; Ginsberg, Henry N; Sapp, John; Rimm, Eric B; Kirkland, Susan; Cahill, Leah E.
Affiliation
  • Warren RA; 1Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Carew AS; 2Queen Elizabeth II Health Sciences Centre, Nova Scotia Health, Halifax, Nova Scotia, Canada.
  • Andreou P; 3Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Herman C; 1Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Levy AP; 2Queen Elizabeth II Health Sciences Centre, Nova Scotia Health, Halifax, Nova Scotia, Canada.
  • Ginsberg HN; 3Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Sapp J; 1Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Rimm EB; 2Queen Elizabeth II Health Sciences Centre, Nova Scotia Health, Halifax, Nova Scotia, Canada.
  • Kirkland S; 4Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Cahill LE; 5Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
Diabetes Care ; 45(1): 241-250, 2022 01 01.
Article in En | MEDLINE | ID: mdl-34785535
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fenofibrate / Diabetes Mellitus, Type 2 Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Diabetes Care Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fenofibrate / Diabetes Mellitus, Type 2 Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Diabetes Care Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United States